Loading…
Modulation of adenosine receptor affinity and intrinsic efficacy in adenine nucleosides substituted at the 2-position
We have studied the structural determinants of binding affinity and efficacy of adenosine receptor (AR) agonists. Substituents at the 2-position of adenosine have been combined with N 6-substitutions known to enhance human A 3AR affinity. The environment surrounding the 2-position within the putativ...
Saved in:
Published in: | Bioorganic & medicinal chemistry 2004-06, Vol.12 (11), p.2995-3007 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | We have studied the structural determinants of binding affinity and efficacy of adenosine receptor (AR) agonists. Substituents at the 2-position of adenosine have been combined with
N
6-substitutions known to enhance human A
3AR affinity. The environment surrounding the 2-position within the putative A
3AR binding site was explored using rhodopsin-based homology modeling and ligand docking.
We studied the structural determinants of binding affinity and efficacy of adenosine receptor (AR) agonists. Substituents at the 2-position of adenosine were combined with
N
6-substitutions known to enhance human A
3AR affinity. Selectivity of binding of the analogues and their functional effects on cAMP production were studied using recombinant human A
1, A
2A, A
2B, and A
3ARs. Mainly sterically small substituents at the 2-position modulated both the affinity and intrinsic efficacy at all subtypes. The 2-cyano group decreased hA
3AR affinity and efficacy in the cases of
N
6-(3-iodobenzyl) and
N
6-(
trans-2-phenyl-1-cyclopropyl), for which a full A
3AR agonist was converted into a selective antagonist; the 2-cyano-
N
6-methyl analogue was a full A
3AR agonist. The combination of
N
6-benzyl and various 2-substitutions (chloro, trifluoromethyl, and cyano) resulted in reduced efficacy at the A
1AR. The environment surrounding the 2-position within the putative A
3AR binding site was explored using rhodopsin-based homology modeling and ligand docking. |
---|---|
ISSN: | 0968-0896 1464-3391 |
DOI: | 10.1016/j.bmc.2004.03.031 |